Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2013.0253


Advances in gastric cancer: laparoscopic total gastrectomy, trastuzumab-emtansine and integrated genomic analysis.

Prof. Theodore Liakakos, MD, PhD

Affiliation: Theodore Liakakos, MD, Professor of Surgery, 3rd Department of Surgery, University of Athens, School of Medicine, Attikon University Hospital, Rimini 1, Chaidari, Athens 12462, Greece.


Since there is no abstract available we provide the first paragraph
Despite its declining incidence, adenocarcinoma of the stomach treatment has rapidly progress in the treatment of. Gastric cancer still remains a major health problem in East Asia but not in the USA and North-West Europe because of sharp reduction in the incidence of the disease in these geographical areas. Laparoscopic surgery, trastuzumab-emtansine drug and genome architecture-based research represent the latest advances in the effort to improve quality of life and oncological outcome of patients with this condition.

(Citation: Gastric & Breast Cancer 2013; 12(1): xx-xx)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 11 January 2013